SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007427
Filing Date
2021-05-17
Accepted
2021-05-17 17:08:34
Documents
63
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nrbo-20210331x10q.htm 10-Q 890054
2 EX-10.4 nrbo-20210331ex104294936.htm EX-10.4 23612
3 EX-31.1 nrbo-20210331ex311fb4ebe.htm EX-31.1 17144
4 EX-32.1 nrbo-20210331ex3216943b8.htm EX-32.1 10968
5 GRAPHIC nrbo-20210331ex104294936001.jpg GRAPHIC 3634
  Complete submission text file 0001558370-21-007427.txt   4189877

Data Files

Seq Description Document Type Size
6 EX-101.INS nrbo-20210331.xml EX-101.INS 769032
7 EX-101.SCH nrbo-20210331.xsd EX-101.SCH 41333
8 EX-101.CAL nrbo-20210331_cal.xml EX-101.CAL 37291
9 EX-101.DEF nrbo-20210331_def.xml EX-101.DEF 139397
10 EX-101.LAB nrbo-20210331_lab.xml EX-101.LAB 354994
11 EX-101.PRE nrbo-20210331_pre.xml EX-101.PRE 268663
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37809 | Film No.: 21932173
SIC: 2834 Pharmaceutical Preparations